Terms: = Leukemia AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
141 results:
1. Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Dunbar AJ; Bowman RL; Park YC; O'Connor K; Izzo F; Myers RM; Karzai A; Zaroogian Z; Kim WJ; Fernández-Maestre I; Waarts MR; Nazir A; Xiao W; Codilupi T; Brodsky M; Farina M; Cai L; Cai SF; Wang B; An W; Yang JL; Mowla S; Eisman SE; Hanasoge Somasundara AV; Glass JL; Mishra T; Houston R; Guzzardi E; Martinez Benitez AR; Viny AD; Koche RP; Meyer SC; Landau DA; Levine RL
Cancer Discov; 2024 May; 14(5):737-751. PubMed ID: 38230747
[TBL] [Abstract] [Full Text] [Related]
2. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway.
Zhang J; Dai H; Huo L; Burks JK; McGrail DJ; Lin SY
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907220
[TBL] [Abstract] [Full Text] [Related]
3. Mediators of Black-White inequities in cardiovascular mortality among survivors of 18 cancers in the USA.
Sung H; Hyun N; Ohman RE; Yang EH; Siegel RL; Jemal A
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 37471575
[TBL] [Abstract] [Full Text] [Related]
4. Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis.
Ollila TA; Taher R; Moku P; Olszewski AJ
Blood Adv; 2023 Sep; 7(18):5470-5479. PubMed ID: 37459209
[TBL] [Abstract] [Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Maffini E; Ngoya M; Galimard JE; Harbi S; Kröger N; Platzbecker U; Sengeloev H; Craddock C; Potter V; Choi G; Chevallier P; Stölzel F; Tholouli E; Maertens J; Ciceri F; Cornelissen J; Sanz J; Spyridonidis A; Lanza F; Nagler A; Mohty M
Bone Marrow Transplant; 2023 Sep; 58(9):1033-1041. PubMed ID: 37386253
[TBL] [Abstract] [Full Text] [Related]
6. Cost-effectiveness analysis of imatinib versus dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia when combined with conventional chemotherapy in China.
Chen M; Liu L; Zhang L; Lin Y; Lu X; Yang H; Ni J
BMC Health Serv Res; 2023 Jun; 23(1):652. PubMed ID: 37331932
[TBL] [Abstract] [Full Text] [Related]
7. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Döhner H; Weber D; Krzykalla J; Fiedler W; Kühn MWM; Schroeder T; Mayer K; Lübbert M; Wattad M; Götze K; Fransecky L; Koller E; Wulf G; Schleicher J; Ringhoffer M; Greil R; Hertenstein B; Krauter J; Martens UM; Nachbaur D; Samra MA; Machherndl-Spandl S; Basara N; Leis C; Schrade A; Kapp-Schwoerer S; Cocciardi S; Bullinger L; Thol F; Heuser M; Paschka P; Gaidzik VI; Saadati M; Benner A; Schlenk RF; Döhner K; Ganser A;
Lancet Haematol; 2023 Jul; 10(7):e495-e509. PubMed ID: 37187198
[TBL] [Abstract] [Full Text] [Related]
8. Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia.
Cheng CK; Yung YL; Chan HY; Leung KT; Chan KYY; Leung AWK; Cheng FWT; Li CK; Wan TSK; Luo X; Pitts HA; Cheung JS; Chan NPH; Ng MHL
Commun Biol; 2023 Mar; 6(1):356. PubMed ID: 37002311
[TBL] [Abstract] [Full Text] [Related]
9. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia.
Lai W; Wang X; Liu L; Xu L; Mao L; Tan J; Zha X; Zhan H; Lei W; Lan Y; Chen G; Li Y; Luo OJ
Front Immunol; 2022; 13():957436. PubMed ID: 36532049
[TBL] [Abstract] [Full Text] [Related]
11. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
[TBL] [Abstract] [Full Text] [Related]
12. Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Stefanski HE; Eaton A; Baggott C; Rossoff J; Verneris MR; Prabhu S; Pacenta HL; Phillips CL; Talano JA; Moskop A; Margossian SP; Myers GD; Karras NA; Brown PA; Qayed M; Hermiston M; Satwani P; Krupski MC; Keating AK; Wilcox R; Rabik CA; Fabrizio VA; Chinnabhandar V; Goksenin AY; Curran KJ; Mackall CL; Laetsch TW; Schultz LM
Blood Adv; 2023 Feb; 7(4):541-548. PubMed ID: 35938863
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
[TBL] [Abstract] [Full Text] [Related]
14. Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
Kim K; Konopleva M; DiNardo CD; Borthakur G; Loghavi S; Tang G; Daver N; Pemmaraju N; Jabbour E; Rausch CR; Yilmaz M; Sasaki K; Short NJ; Jain N; Brandt M; Pierce S; Garcia-Manero G; Ravandi F; Kantarjian H; Kadia TM
Am J Hematol; 2022 Jul; 97(7):885-894. PubMed ID: 35413152
[TBL] [Abstract] [Full Text] [Related]
15. [Effect of Age on the Time of Neutropenia after Initial Induction Therapy for Patients with Newly Diagnosed Acute Myeloid leukemia].
Jia XY; Chen L; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):43-48. PubMed ID: 35123602
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical features and prognosis of low triiodothyronine syndrome in patients with acute myeloid leukemia].
Li LZ; Hu JH; Xu ZY; Hong M; Sun Q; Qian SX; Liu WJ
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):923-929. PubMed ID: 35045654
[No Abstract] [Full Text] [Related]
17. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.
Lynggaard LS; Rank CU; Hansen SN; Gottschalk Højfeldt S; Henriksen LT; Jarvis KB; Ranta S; Niinimäki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
Blood Adv; 2022 Jan; 6(1):138-147. PubMed ID: 34625787
[TBL] [Abstract] [Full Text] [Related]
18. PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.
Teye EK; Lu S; Chen F; Yang W; Abraham T; Stairs DB; Wang HG; Yochum GS; Brodsky RA; Pu JJ
Sci Rep; 2021 Sep; 11(1):19022. PubMed ID: 34561473
[TBL] [Abstract] [Full Text] [Related]
19. External background ionizing radiation and childhood cancer: Update of a nationwide cohort analysis.
Mazzei-Abba A; Folly CL; Kreis C; Ammann RA; Adam C; Brack E; Egger M; Kuehni CE; Spycher BD
J Environ Radioact; 2021 Nov; 238-239():106734. PubMed ID: 34521026
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.
Wang Y; Zhou W; McReynolds LJ; Katki HA; Griffiths EA; Thota S; Machiela MJ; Yeager M; McCarthy P; Pasquini M; Wang J; Karaesmen E; Rizvi A; Preus L; Tang H; Wang Y; Pooler L; Sheng X; Haiman CA; Van Den Berg D; Spellman SR; Wang T; Kuxhausen M; Chanock SJ; Lee SJ; Hahn TE; Sucheston-Campbell LE; Gadalla SM
Sci Rep; 2021 Jul; 11(1):15004. PubMed ID: 34294836
[TBL] [Abstract] [Full Text] [Related]
[Next]
